AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+8.91%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$149M
AUM Growth
+$149M
(-15%)
Cap. Flow
-$34.7M
Cap. Flow
% of AUM
-23.3%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
297
New
63
Increased
40
Reduced
80
Closed
81
Top Buys
| 1 |
ABVX
Abivax
ABVX
|
$2.86M |
| 2 |
Pfizer
PFE
|
$2.3M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
$2.1M |
| 4 |
Invesco QQQ Trust
QQQ
|
$2.1M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$1.93M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$3.38M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$2.95M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$2.78M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$2.74M |
| 5 |
TSVT
2seventy bio
TSVT
|
$2.58M |
Sector Composition
| 1 | Healthcare | 59.47% |
| 2 | Real Estate | 11.94% |
| 3 | Financials | 4.93% |
| 4 | Industrials | 2.46% |
| 5 | Consumer Discretionary | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
KalVista Pharmaceuticals
KALV
$713M
| $1.68M | 1.13% |
137,000
+2,000
| +1% | +$24.5K |
|
|
MFA
27
MFA Financial
MFA
$1.05B
| $1.61M | 1.08% |
142,725
-60,000
| -30% | -$676K |
|
28
Immunovant
IMVT
$2.91B
| $1.6M | 1.07% |
38,000
| – | – |
|
29
VYNE Therapeutics
VYNE
$8.09M
| $1.56M | 1.05% |
+668,151
| New | +$1.56M |
|
30
MGIC Investment
MTG
$6.47B
| $1.53M | 1.03% |
79,379
| – | – |
|
31
Mirum Pharmaceuticals
MIRM
$3.75B
| $1.48M | 0.99% |
+50,000
| New | +$1.48M |
|
32
Equity Lifestyle Properties
ELS
$11.7B
| $1.45M | 0.98% |
20,611
| – | – |
|
|
ITCI
33
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.43M | 0.96% |
20,000
-5,500
| -22% | -$394K |
|
34
Mr. Cooper
COOP
$12.1B
| $1.41M | 0.94% |
21,591
-9,699
| -31% | -$632K |
|
35
Dynavax Technologies
DVAX
$1.19B
| $1.4M | 0.94% |
100,000
-10,000
| -9% | -$140K |
|
|
ONC
36
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $1.35M | 0.91% |
+7,500
| New | +$1.35M |
|
37
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.35M | 0.91% |
14,000
-2,500
| -15% | -$241K |
|
|
MITT
38
AG Mortgage Investment Trust
MITT
$245M
| $1.33M | 0.89% |
208,879
| – | – |
|
39
GSK
GSK
$79.3B
| $1.3M | 0.87% |
35,000
-15,000
| -30% | -$556K |
|
40
Jazz Pharmaceuticals
JAZZ
$7.99B
| $1.29M | 0.87% |
10,500
-16,000
| -60% | -$1.97M |
|
41
Symbotic
SYM
$5.06B
| $1.28M | 0.86% |
25,000
| – | – |
|
42
Intuitive Surgical
ISRG
$158B
| $1.27M | 0.85% |
3,750
| – | – |
|
43
Enact Holdings
ACT
$5.57B
| $1.22M | 0.82% |
42,367
| – | – |
|
44
Structure Therapeutics
GPCR
$1.14B
| $1.22M | 0.82% |
+30,000
| New | +$1.22M |
|
45
Verastem
VSTM
$585M
| $1.22M | 0.82% |
150,000
| – | – |
|
46
Royalty Pharma
RPRX
$15.8B
| $1.12M | 0.75% |
+40,000
| New | +$1.12M |
|
|
VRNA
47
Verona Pharma
VRNA
$9.18B
| $1.11M | 0.75% |
56,000
| – | – |
|
|
KRTX
48
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.11M | 0.74% |
3,500
+2,750
| +367% | +$870K |
|
|
RWT
49
Redwood Trust
RWT
$793M
| $1.09M | 0.73% |
146,593
| – | – |
|
50
Synopsys
SNPS
$110B
| $1.08M | 0.73% |
2,100
| – | – |
|